Pacific Biosciences Of California (PACB)
EBITDA Margin
-97.55%
Quarterly · Period ending:
PACB EBITDA Margin
Latest reported-97.55%period ending
Latest reported-97.55%period ending
PACB Quarterly EBITDA Margin (0.00% → -97.55%)
Quarterly ebitda margin
High-resolution chart · PNG
PACB ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -97.5517% | |
| -15.5092% | |
| -75.6636% | |
| -81.8917% | |
| -89.4608% | |
| -139.5877% | |
| 41.7933% | |
| -102.8048% | |
| -431.7552% | |
| -161.2703% | |
| -115.6091% | |
| -123.0576% | |
| -129.0963% | |
| -205.3188% | |
| -276.8618% | |
| -213.5248% | |
| -179.3216% | |
| -222.3585% | |
| -168.2168% | |
| -206.5239% | |
| -114.4038% | |
| -287.3539% | |
| 284.8062% | |
| -112.1056% | |
| -121.8832% | |
| 24.9712% | |
| 11.092% | |
| -118.1702% | |
| -87.4294% | |
| -165.9056% | |
| -145.4061% | |
| -124.4659% | |
| -93.3034% | |
| -112.571% | |
| -73.5031% | |
| -83.2236% | |
| -113.2068% | |
| -80.9914% | |
| -66.6278% | |
| -62.4015% | |
| -82.3975% | |
| -92.6282% | |
| -0.2177% | |
| -140.6984% | |
| -41.7819% | |
| -104.3922% | |
| -100.4733% | |
| -35.9453% | |
| -150.6521% | |
| -146.2292% | |
| -170.7248% | |
| -250.5592% | |
| -307.4239% | |
| -342.6676% | |
| -341.7149% | |
| -755.5115% | |
| -283.8294% | |
| -257.8302% | |
| -170.2186% | |
| -266.147% | |
| -200.1505% | |
| -12,407.037% | |
| -12,547.1429% | |
| -17,842.2727% | |
| -5,002.5437% | |
| -5,362.0183% | |
| -19,425.9259% | |
| 0% |